No Data
No Data
Top Gap Ups and Downs on Tuesday: LI, PHG, MSTR and More
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Is Genmab (GMAB) One of the Best Growth Stocks to Invest In According to Analysts?
Bispecific Antibody and Cancer Patent Landscape Analysis 2025, With IP Profiles of Key Players Amgen, Genentech, Roche, GenMab, Janssen, Regeneron and Xencor - ResearchAndMarkets.com
Truist Financial Maintains Genmab(GMAB.US) With Buy Rating
TD Cowen Maintains Genmab(GMAB.US) With Hold Rating